Document Details

Document Type : Article In Journal 
Document Title :
The future of osteoarthritis therapeutics: targeted pharmacological therapy
The future of osteoarthritis therapeutics: targeted pharmacological therapy
 
Document Language : English 
Abstract : steoarthritis (OA) is one of the most common forms of degenerative joint disease and a major cause of pain and disability affecting the aging population. It is estimated that more than 20 million Americans and 35 to 40 million Europeans suffer from OA. Analgesics and non-steroidal anti-inflammatory drugs (NSAIDs) are the only therapeutic treatment options for OA. Effective pharmacotherapy for OA, capable of restoring the original structure and function of damaged cartilage and other synovial tissue, is urgently needed, and research into such disease-modifying osteoarthritis drugs (DMOADs) is in progress. This is the first of three reviews focusing on OA therapeutics. This paper provides an overview of current research into potential structure-modifying drugs and more appropriately targeted pharmacological therapy. The challenges and opportunities in this area of research and development are reviewed, covering the most up-to-date initiatives, trends, and topics. 
ISSN : 1523-3774 
Journal Name : Current rheumatology reports 
Volume : 15 
Issue Number : 10 
Publishing Year : 1434 AH
2013 AD 
Article Type : Article 
Added Date : Tuesday, March 15, 2016 

Researchers

Researcher Name (Arabic)Researcher Name (English)Researcher TypeDr GradeEmail
Ali MobasheriMobasheri, Ali Investigator  

Files

File NameTypeDescription
 38385.pdf pdf 

Back To Researches Page